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Klebsiella pneumoniae is among the most important causes of urinary tract
infection (UTI). The aim of this study was to investigate the prevalence and correlation
of antibiotic resistance with virulence characteristics and genetic diversity in
K. pneumoniae isolated from UTIs in Iran. Phenotypic tests and antibiotic suscepti-
bility were carried out on the isolates. Detection of the virulence and extended-
spectrum β-lactamase (ESBL) genes was performed by polymerase chain reaction.
Pulsed-field gel electrophoresis (PFGE) was used for exploring the genomic related-
ness. Hemolysin, biofilm, and hypermucoviscosity formation were observed in 87.1%,
86.4%, and 12.1% of isolates, respectively. The antibiotic resistance rate of
K. pneumoniae isolates ranged from 12.1% for meropenem to 100% for amoxicillin.
The prevalence of virulence genes ranged from 1.4% for cnf-1 to 100% for mrkD,
fimH, kpn, and entB genes. In this study, 91.7%, 33.3%, and 4.2% of phenotypically
ESBL-producers were positive for blaCTX-M, blaTEM, and blaSHV genes, respectively.
An association was observed between the presence of traT, fyuA, or cnf-1 genes with
antibiotic resistance. Two clone types were obtained by PFGE that indicate different
K. pneumoniae clones in community- and hospital-acquired UTIs. The findings of this
study are valuable in development of treatment strategies against UTIs in Iran.
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Introduction
Urinary tract infections (UTIs) are among prevalent infections acquired both
in community and in hospitals. It is estimated that 40% of women will have a UTI
with a rate of 25% for recurrent UTIs [1]. Klebsiella pneumoniae is recognized as a
common pathogen associated with both community- and hospital-acquired UTIs
[2]. Its pathogenicity is related to expression of a variety of virulence factors
including fimbriae, toxins, iron acquisition systems, lipopolysaccharide, and capsule
[2]. Fimbriae type 1 and type 3 as mannose-sensitive (MSHA) and mannose-
resistant hemagglutination pili (MRHA) play a major role in adherence and
colonization of K. pneumoniae in the urinary tract [3]. FimH and MrkD composed
the tip adhesin of types 1 and 3 pili inK. pneumoniae, respectively, and play relevant
roles in biofilm formation [3]. Biofilms have known roles in pathogenesis of
K. pneumoniae strains, including the resistance to immune responses and acquisition
of antibiotic resistance [4]. Capsule is among the main virulence factors of
K. pneumoniae isolates for protection against host immune system. K1 and K2
capsular serotypes containing the mucoviscosity-associated gene A (magA) were
associated with severe UTI infections [5]. K. pneumoniae strains also have two
potential toxins, a cytolytic pore forming toxin (α-hemolysin) and cytotoxic-
necrotizing factor 1 (CNF1) that cause damage to tissues in the host [6].
Antibiotics are used routinely for therapy of UTIs caused by K. pneumoniae
strains. To date, K. pneumoniae is known worldwide for rapid acquisition of
resistance to different antibiotics, including resistance to β-lactams, fluoroquino-
lones, and carbapenems [7, 8]. Antibiotic resistance among the K. pneumoniae
strains poses a great threat to public health and imposes a high cost to the UTI
patients [9]. Resistance of these isolates to antibiotics is acquired by different
mechanisms such as production of β-lactamase enzymes named as extended-
spectrum β-lactamases (ESBLs) [10]. TEM, SHV, and CTX-M as the most
common ESBL types confer resistance to all β-lactam antibiotics, except for
carbapenems, and β-lactamase inhibitors. Furthermore, ESBL-producing isolates
usually carry other resistance genes that confer resistance to other classes of
antibiotics, such as aminoglycosides and quinolones [10, 11]. Unfortunately,
many physicians prescribe that antibiotics before the results of antibiotic sensitivi-
ty can be evaluated by the laboratories. Thus, the choice of effective antibiotics
against UTIs caused by K. pneumoniae should be based on determination the
causative agent and knowledge of the resistance patterns of the isolate [12].
K. pneumoniae is recognized as one of the most important opportunistic
pathogens in UTIs; however, there are only a few studies about pathogenicity and
correlation between the virulence factors with antibiotic resistance in these isolates
in Iran. Thus, the objectives of this study were to investigate the prevalence and
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correlation of the virulence factors with antibiotic resistance in K. pneumoniae
isolated from outpatients and inpatients in Tehran, Iran. Then, the clonal related-
ness among the K. pneumoniae isolates was evaluated by pulsed-field gel
electrophoresis (PFGE) technique.
Methods
Collection of K. pneumoniae isolates from UTI patients
From July to December 2017, 140K. pneumoniae isolates were collected from
the urine samples of outpatients (n= 80) and inpatients (n= 60) in several hospitals
in Tehran, Iran. Patients were informed about the project and provided the informed
consent. The exclusion criteria in this study were the presence of fungi, mixed
cultures, and age less than 18 years. The urine samples were collected from the clean
catch mid-stream urine of the patients. After collection of the urine with colony
count ≥105 CFU/ml, identification of K. pneumoniae isolates in these samples was
performed on the basis of standard microbiological and biochemical tests.
Phenotypic determination of virulence factors
Hemagglutination assay. K. pneumoniae isolates were screened for type 1 (MSHA)
and type 3 fimbriae (MRHA). Briefly, bacterial suspensions and human erythro-
cytes of blood group O (3%) were added to the 96-well microtiter plates in the
presence and absence of D-mannose 2%. The plates were incubated at room
temperature and reported as MRHA when agglutination was observed in
the presence of mannose and MSHA when it was not occurred with mannose.
The wells containing erythrocytes in the presence and absence of mannose were
applied as negative controls and Escherichia coli ATCC 25922 as positive control
for MRHA phenotype.
Hemolysin production. The phenotypic ability of the K. pneumoniae isolates in
production of α-hemolysin was evaluated in culture media. The isolates were
cultured in 5% sheep blood agar (Merck, Germany) and incubated overnight at
37 °C. Production of a clear zone of lysed erythrocytes around the colonies was
considered as hemolysin producer isolate.
Biofilm formation testing. The ability of the K. pneumoniae isolates to produce
biofilm was monitored by a microtiter plate test. Briefly, K. pneumoniae isolates
were subcultured in lysogeny broth, diluted at 1:100 ratio, and incubated for 48 h.
After several washes, 0.5% of crystal violet was added to plates and incubated for
15 min at room temperature. The plates were washed and a mixture of 33% acetic
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acid and 80% ethanol was added to plates to dissolve the crystal violet and plates
read at absorbance 590 nm with ELISA reader (BIO-TEK, USA). The
K. pneumoniae isolates were classified as strong biofilm producers [(2.5 ≤ optical
density (OD)], moderate producers (1.5 ≤ OD< 2.5), weak producers (0.7 ≤ OD≤
1.5), and non-biofilm producers isolates (OD≤ 0.7). E. coli ATCC 25922 and
Pseudomonas aeruginosa strains were used as positive controls and E. coliDH5α as
a negative control.
Hypermucoviscosity (HMV) test. The string test was applied to evaluate the
HMV phenotype of the isolates [13]. The K. pneumoniae isolates were cultured on
5% sheep blood agar plates and incubated for 18–24 h at 37 °C. When an
inoculation loop was touched onto the surface of the colonies and slowly raised,
the formation of a viscous string of at least 5 mm in length was considered as a
HMV-positive phenotype.
Antibiotic susceptibility test. Antimicrobial susceptibility patterns of the isolates
to different antibiotics were evaluated using the disk diffusion method using
Mueller–Hinton agar (Merck). The tested antibiotics (Mast, Co., Merseyside, UK)
were amoxicillin (10 μg), ticarcillin (75 μg), ampicillin–sulbactam (10+ 10 μg),
cephalotin (30 μg), cephalexin (30 μg), ceftazidime (30 μg), cefotaxime (30 μg),
meropenem (10 μg), nalidixic acid (30 μg), norfloxacin (10 μg), gentamicin
(10 μg), tobramycin (10 μg), and trimethoprim–sulfamethoxazole (SXT; 30 μg).
The results were interpreted according to the Clinical and Laboratory Standards
Institute (CLSI) recommendations [14]. The E. coli ATCC 25922 was used
as control strain. Isolates that were resistant to at least three different classes
of antimicrobial agents were determined to be multidrug-resistant (MDR)
phenotypes.
Screening of ESBL isolates. The K. pneumoniae isolates were screened for ESBL
production by combined disk method according to CLSI guidelines [14]. The
phenotypic confirmatory test was performed by ceftazidime (30 μg) alone,
combined with clavulanic acid (10 μg) as well as cefotaxime (30 μg) alone, and
combined with clavulanic acid (10 μg) disks. E. coli ATCC 25922 and
K. pneumoniae ATCC 700603 were applied as negative and positive controls,
respectively.
DNA extraction and polymerase chain reaction (PCR) detection of virulence and
ESBL genes. PCR was applied to detect the virulence genes encoding adhesins
(fimH and mrkD), fimH-like adhesin (Kpn), entrobactin biosynthesis (entB),
yersiniabactin iron receptor (fyuA), serum resistance-associated outer membrane
lipoprotein (traT), magA, α-hemolysin (hlyA), and cnf-1. Furthermore, the pres-
ence of blaTEM, blaSHV, and blaCTX-M in the ESBL-producing isolates was
confirmed by PCR. All specific primers (Genfanavaran, Iran) are listed in
Table I. PCR reactions contained 1× buffer, 0.1 mM dNTPs, 2.5 mM MgCl2,
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50 pmol of each primer, and 0.5 U Taq polymerase (CinnaGen, Iran) in a total
volume of 25 μl. The used programs were an initial denaturation (94 °C for 5 min),
followed by 30 cycles at denaturation (94 °C for 1 min), annealing (specific
temperature for 1 min; Table I) and extension (72 °C for 1 min), and a final step
(72 °C for 5 min).
PFGE analysis. PFGE was performed on 45 selected isolates to determine
genomic diversity of the isolates. Briefly, these isolates were cultured on trypticase
soy agar and then prepared bacterial plugs lysed with lysis buffer. The plugs were
digested with restriction enzyme XbaI (Fermentas, Lithuania) for about 150 min at
37 °C. Then, electrophoresis of the plugs was performed in agarose 1% (Ultrapure,
Invitrogen, USA) with CHEF-DR III system (Bio-Rad, USA). The stained gels
with ethidium bromide were observed with Gel Doc. The obtained patterns were
analyzed using GelCompare II, version 6.5 software (Applied Maths, St Martens-
Latem, Belgium). Dendrogram drawing and clonal associations between the
genotypes were performed with average linkage method and analyzed with
unweighted pair group method analysis [15].
Table I. Primers used to amplify virulence and ESBL genes in K. pneumoniae isolates
Target Primer sequence (5′–3′) Annealing temperature (°C) Size (bp)
fimH-1 F: ATGAACGCCTGGTCCTTTGC 55 688
R: GCTGAACGCCTATCCCCTGC
mrkD F: CCACCAACTATTCCCTCGAA 52 240
R: ATGGAACCCACATCGACATT
Kpn F: GTATGACTCGGGGAAGATTA 55 626
R: CAGAAGCAGCCACCACACG
entB F: ATTTCCTCAACTTCTGGGGC 57 371
R: AGCATCGGTGGCGGTGGTCA
fyuA F: GCGACGGGAAGCGATGATTTA 55 547
R: TAAATGCCAGGTCAGGTCACT
tratT F: GGTGTGGTGCGATGAGCACAG 63 290
R: CACGGTTCAGCCATCCCTGAG
magA F: GTGCTCTTTACATCATTGC 59 1,282
R: GCAATGGCCATTTGCGTTAG
hlyA F: AACAAGGATAAGCACTGTTCTGGCT 62 1,177
R: ACCATATAAGCGGTCATTCCCGTCA
cnf1 F: AGATGGAGTTTCCTATGCAGGAG 56 498
R: CATTCAGAGTCCTGCCCTCATTATT
blaTEM F: ATGAGTATTCAACATTTCCG 53 931
R: CCAATGCTTAATCAGTGAGC
blaSHV F: CTTTACTCGCTTTATCG 53 867
R: TCCCGCAGATAAATCAC
blaCTX-M F: TCTTCCAGAATAAGGAATCCC 51 593
R: CCGTTTCCGCTATTACAAAC
Note: ESBL: extended-spectrum β-lactamase; F: forward; R: reverse.
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Statistical analysis
Statistical data analysis was performed using SPSS software version 19.0
for Windows (IBM, Chicago, USA). Among the statistical tests, χ2, two-tailed
Fisher’s exact, and analysis of variance tests were used to assess and compare the
relationships between various virulence factors in K. pneumoniae. Moreover, pair
gene relationships were assessed using Phi coefficients. The p value <0.05 was
considered for all statistical accounts.
Results
Prevalence of UTI in relationship with profile of patients
Among the UTI patients included in this study, the rate of UTI in females
(78.6%) was higher than males (21.4%). The age range of patients was 18–85
years. The frequency of K. pneumoniae in different age groups was 18–40
(44.3%), 41–60 (37.8%), and 61–85 (17.9%) years. Distribution of the inpatient
isolates according to the hospital settings was urology (31.6%), intensive care
unit (ICU; 25%), gynecology (18.4%), coronary care unit (CCU; 15%), and
surgery (10%).
Phenotypic characteristics of K. pneumoniae isolates
Phenotypic virulence characteristics. It was found that 87.1% of the isolates had the
ability to produce hemolysin. The hemolysin activity was found in 93.3%
and 82.5% of isolates collected from inpatients and outpatients, respectively.
Furthermore, the distribution of hemolysin-positive isolates in different hospital
settings was ICU (100%), CCU (100%), surgery (100%), urology (89.5%), and
gynecology (81.8%). Furthermore, 22.2% and 77.8% of the non-hemolysin
producer isolates were recovered from inpatients and outpatients, respectively.
According to our results, 86.4% of K. pneumoniae produced biofilm that
were classified into strong (24%), moderate (54.5%), and weak biofilm producers
(21.5%). In addition, 91.7% and 82.5% of biofilm producer isolates were collected
from inpatients and outpatients, respectively. All isolates that were collected from
ICU, CCU, and gynecology wards had the ability to form strong to moderate
biofilm formation. The isolates that had no ability in biofilm production were
collected from age group 18–40 (79%), 41–60 (10.5%), and 61–85 (10.5%) years.
It was found that among 122 hemolysis-positive isolates, altogether 110 (90.2%)
had the ability for biofilm formation (p= 0.004).
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The HMV phenotype was found in 17 (12.1%) of isolates in which
15 (88.2%) and 2 (11.8%) of them were isolated from inpatients and outpatients,
respectively (p= 0.001). Based on our investigations, all K. pneumoniae isolates
showed the presence of type 1 (MSHA) and type 3 fimbriae (MRHA).
Antibiotic susceptibility of K. pneumoniae isolates. According to the disk
diffusion results, the susceptibility of K. pneumoniae isolates to antibiotics was
meropenem (87.9%), norfloxacin (77.1%), gentamicin (75.7%), tobramycin
(75.7%), nalidixic acid (75%), ampicillin–sulbactam (66.4%), ceftazidime (65%),
cefotaxime (62.1%), SXT (61.4%), cephalotin (60.7%), cephalexin (60.7%), and
ticarcillin (12.9%). Furthermore, all isolates were resistant to amoxicillin. As
shown in Table II, 53 of the isolates with co-resistance to amoxicillin and
ticarcillin were the most frequent resistance pattern (R1), whereas 12 isolates
showed single patterns (data not shown).
The distribution of antibiotic resistance according to the outpatients and
inpatients is also shown in Table III. Among the antibiotics tested, there was a
significant difference between the resistance to all antibiotics in inpatients and
outpatients groups (p< 0.05; Table III).
According to the results, 33 (23.6%) of K. pneumoniae isolates were
classified as MDR isolates. Out of 33 MDR isolates, 14 (42.4%) were completely
resistant to all antibiotics investigated. MDR in females was higher than males
(26 vs. 7), but these differences were not statistically significant (p> 0.05).
Table II. Antibiotic resistance patterns of K. pneumoniae isolates
Pattern name Resistance patterns
No. of
isolates
R1 AMX, TC 52
R2 AMX 18
R3 AMX, TC, CL, KF, CTX, CAZ, SAM, SXT, NOR, MEM, GEN, TB, NAL 14
R4 AMX, TC, SXT 10
R5 AMX, TC, CL, KF, CTX, CAZ, SAM, SXT 6
R6 AMX, TC, CL, KF, CTX, CAZ, SXT 6
R7 AMX, TC, CL, KF, CTX, CAZ, SAM, SXT, NOR, GEN, TB, NAL 6
R8 AMX, TC, CL, KF, CTX, CAZ, SXT, NOR, GEN, TB, NAL 3
R9 AMX, TC, CL, KF, CTX, CAZ, SAM, GEN, TB 3
R10 AMX, TC, SAM, SXT, GEN, TB, NAL 2
R11 AMX, TC, CL, KF, CTX, CAZ, SAM, NOR, NAL 2
R12 AMX, TC, CL, KF, CTX, CAZ, SAM, SXT, NOR, NAL 2
R13 AMX, TC, SAM 2
R14 AMX, TC, CTX, CAZ, CL, KF, SAM, NOR, MEM, GEN, TB, NAL 2
Note: AMX: amoxicillin; TC: ticarcillin; CRO: ceftriaxone; CAZ: ceftazidime; CL: cephalexin;
KF: cephalotin; SAM: ampicillin–sulbactam; SXT: trimethoprim–sulfamethoxazole; NOR: norfloxacin;
GEN: gentamicin; TB: tobramycin; NAL: nalidixic acid; MEM: meropenem.
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Furthermore, 51.5% of MDR isolates were in the age groups of 41–60, 30.3% in
18–40, and 18.2% in 61–85 years. Twenty-nine isolates of MDR isolates were
collected from inpatients and four isolates from outpatients. In addition, the
distribution of MDR isolated from inpatients in different hospital wards was ICU
(31%), urology (24.2%), gynecology (20.7%), CCU (13.8%), and surgery (10.3%).
The ESBL phenotypic screening by combined disk test showed that among
140 isolates, 48 isolates (34.3%) were ESBL producers. Among the ESBL
producers, 35 (72.9%) belonged to inpatients and 13 (27.1%) to outpatients
(p= 0.0001). Table IV demonstrates the antimicrobial resistance pattern of ESBL-
producing isolates for applied antibiotics. All ESBL-positive isolates exhibited
resistance to ticarcillin, cephalotin, cephalexin, and cefotaxime. Furthermore, the
ESBL-positive isolates exhibited the lowest resistance to meropenem (33.3%;
Table IV).
Distribution of virulence genes among K. pneumoniae isolates. According to our
results, fimH and mrkD adhesins, siderophore receptor gene entB, and fimH-like
adhesin (kpn) were detected in 100% of the isolates. The prevalence rate of traT,
iron receptor gene fyuA, and magA capsular gene was 60%, 37.9%, and 3.6%,
respectively. Toxins α-hemolysin (hlyA) and cnf-1 were present in 7.1% and 1.4%
of isolates, respectively. The prevalence and distribution of different virulence
genes according to the inpatients and outpatients is shown in Table V. It was found
that isolates from inpatients had more virulence genes as compared to the isolates
Table III. Distribution of antibiotic resistance according to the outpatients and inpatients
Antibiotic list
No. (%) of antibiotic
resistance
Total no. (%) of
positive isolates
(n= 140)
p
value
Inpatients
(n= 60)
Outpatients
(n= 80)
β-lactams Ticarcillin 57 (95.0%) 65 (81.2%) 122 0.020
Cephalotin 37 (61.7%) 18 (22.5%) 55 0.000
Cephalexin 37 (61.7%) 18 (22.5%) 55 0.000
Ceftazidime 36 (60.0%) 15 (18.8%) 51 0.000
Cefotaxime 38 (63.3%) 15 (18.8%) 53 0.000
β-lactam/
β-lactamase
inhibitors
Ampicillin–
sulbactam
38 (63.3%) 9 (11.2%) 47 0.000
Carbapenem Meropenem 15 (25.0%) 2 (2.5%) 17 0.000
Quinolones Nalidixic acid 31 (51.7%) 4 (5.0%) 35 0.000
Norfloxacin 28 (46.7%) 4 (5.0%) 32 0.000
Aminoglycosides Tobramycin 28 (46.7%) 6 (7.5%) 34 0.000
Gentamicin 28 (46.7%) 6 (7.5%) 34 0.000
Sulfonamides Trimethoprim–
sulfamethoxazole
31 (51.7%) 22 (27.5%) 53 0.005
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from outpatients and this difference was significant about cnf-1, magA, and traT
genes (p< 0.05; Table V). Furthermore, it was observed that magA gene was
statistically more frequent among HMV-producing isolates compared with non-
HMV producer isolates (p= 0.001).
Correlation between virulence characteristics and antimicrobial resistance. The
correlation of virulence characteristics with ESBL production and antibiotic resis-
tance is shown in Tables IV and VI, respectively. The correlation between biofilm
Table IV. Prevalence of antibiotic resistance and virulence genes among ESBL-positive
and -negative isolates
Antibiotic list
% (n)
p valueESBL+ (n= 48) ESBL− (n= 92) Total (N= 140)
Ticarcillin 48 (100) 73 (80.4) 122 (87.1) 0.000
Cephalotin 48 (100) 7 (7.6) 55 (39.3) 0.000
Cephalexin 48 (100) 7 (7.6) 55 (39.3) 0.000
Cefotaxime 48 (100) 5 (5.4) 53 (37.9) 0.000
Ceftazidime 47 (97.9) 2 (2.2) 49 (35.0) 0.000
SXT 38 (79.2) 16 (17.6) 54 (38.6) 0.000
SAM 38 (79.2) 9 (9.8) 47 (33.6) 0.000
Meropenem 16 (33.3) 1 (1.1) 17 (12.1) 0.000
Tobramycin 31 (64.6) 3 (3.3) 34 (24.3) 0.000
Gentamicin 31 (64.6) 3 (3.3) 34 (24.3) 0.000
Nalidixic acid 31 (64.6) 4 (4.3) 35 (25.0) 0.000
Norfloxacin 30 (62.5) 2 (2.2) 32 (22.9) 0.000
Virulence genes
traT 32 (66.7) 52 (56.5) 84 (60.0) 0.279
fyuA 25 (52.1) 28 (30.4) 53 (37.9) 0.010
magA 2 (4.2) 3 (3.3) 5 (3.6) 1.000
hlyA 7 (14.6) 3 (3.3) 10 (7.1) 0.032
cnf-1 2 (4.2) 0 (0) 2 (1.4) –
Table V. Distribution of virulence genes according to the inpatients and outpatients
Virulence genes
No. (%) of positive isolates in UTI
patients
No. (%) of positive
isolates
p
value
Inpatients
(n= 60)
Outpatients
(n= 80)
Toxin genes hlyA 6 (10%) 4 (5%) 10 (7.1%) 0.326
cnf1 2 (3.3%) 0 (0) 2 (1.4%) –
Protectin/invasion
genes
magA 5 (8.3%) 0 (0) 5 (3.6%) –
traT 46 (76.7%) 38 (47.5%) 84 (60.0%) 0.001
Iron gene fyuA 26 (43.3%) 27 (33.8%) 53 (37.9%) 0.292
Note: UTI: urinary tract infection.
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production and antimicrobial resistance was found to be statistically significant for
cefotaxime and ceftazidime antibiotics (p< 0.05). In addition, isolates harboring
HMV were more resistant to all of the antibiotics, except ticarcillin (p< 0.05). Our
results showed that there was no significant difference between resistance to the
antibiotics and hemolysin production (p> 0.05; Table IV). According to Table IV,
isolates harboring traT gene were more resistant to aminoglycosides (p< 0.05),
nalidixic acid (p= 0.049), and ampicillin–sulbactam (p= 0.006). Furthermore,
isolates harboring fyuA and hlyA genes showed higher resistance to the first- and
third-generation cephalosporins (p< 0.05).
Genotypic detection of ESBLs. PCR amplification on phenotypically ESBL-
producing isolates (n= 48) showed that 44 (91.7%), 16 (33.3%), and 2 (4.2%)
isolates were positive for blaCTX-M, blaTEM, and blaSHV genes, respectively. Of the
48 phenotypically ESBL-producing isolates, 22.9% and 4.2% of the isolates were
shown to have simultaneously blaTEM+ blaCTX-M and blaSHV+ blaCTX-M genes,
respectively. The prevalence of blaCTX-M and blaTEM alone in the phenotypically
ESBL-positive isolates was 64.5% and 4.2%, respectively. There were only two
ESBL-producing isolates negative for ESBL genes. It was found that the preva-
lence of blaCTX-M and blaTEM was significantly higher in inpatients as compared to
the outpatient isolates (p< 0.05).
Genotypic virulence patterns in K. pneumoniae isolates. In this study, 12
virulence patterns (KP patterns) of K. pneumoniae were obtained by different
combinations of virulence genes (Table VII). All isolates indicated multiple
virulence markers and contained four to seven virulence genes. Three isolates
showed unique patterns, whereas KP1 with the presence of fimH,mrkD, kpn, entB,
and traT was the most prevalent profile among the isolates (37.8%; Table VII).
Table VII. Common virulence patterns identified among the K. pneumoniae isolates
Pattern fimH mrkD kpn entB traT fyuA magA hlyA cnf-1
No. (%)
of isolates
Kp1 + + + + + − − − − 53 (37.8%)
Kp2 + + + + − − − − − 26 (18.6%)
Kp3 + + + + − + − − − 24 (17.1%)
Kp4 + + + + + + − − − 21 (15.0%)
Kp5 + + + + − − − + − 3 (2.2%)
Kp6 + + + + + − + − − 3 (2.2%)
Kp7 + + + + − + − + − 3 (2.2%)
Kp8 + + + + + + + − − 2 (1.4%)
Kp9 + + + + + + − + − 2 (1.4%)
Kp10 + + + + + − − + + 1 (0.7%)
Kp11 + + + + + + − − + 1 (0.7%)
Kp12 + + + + + − − + − 1 (0.7%)
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Genomic analysis of K. pneumoniae isolates by PFGE. Totally, 45 K. pneumoniae
isolates were considered for PFGE analysis, based on the virulence patterns,
antibiotic resistance, and epidemiological data. These isolates were clustered into
41 clonal groups, based on the depicted dendrogram (C1–C41). The isolates showed
9–21 bands in PFGE that most of them had 16 bands (Figure 1). In accordance with
Figure 1.XbaI-digested DNA from 45 K. pneumoniae isolates in PFGE. Dendrogramwas constructed
based on UPGMA using Dice coefficient with a 1.0% band position tolerance, and the scales above the
dendrogram indicate the percentage of similarity. The dotted line indicates 80% similarity
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the similarity coefficient of 80%, only two clone types (C1 and C2) with two isolates
in each were observed. Isolates in C1 were collected from the hospitalized patients in
urology and surgery wards of two different hospitals. Isolates in C2 belonged to
women hospitalized in ICU and gynecological ward and both of them were
recovered in one hospital.
Discussion
Clinicians need to know about virulence properties and antimicrobial
resistance patterns of pathogens causing UTI for a better understanding of these
infections. In this study, we evaluated correlations between virulence properties
and antimicrobial resistance of the K. pneumoniae isolates in UTI patients.
In agreement with the other reports, a high prevalence of virulence genes
fimH, mrkD, kpn, and entB was observed in K. pneumoniae isolates [2, 16] that
indicated their important role in pathogenesis of these isolates. It was found that all
isolates harboring magA were isolated from inpatients that in accordance with
other studies suggest significant role of MagA in pathogenesis of K. pneumoniae
in complicated or severe UTIs [17]. To the best of our knowledge, there is no study
reporting the presence of CNF1 in K. pneumoniae isolated from UTIs, whereas in
this study, cnf1 was detected in two isolates that were recovered from hospitalized
patients. The cnf1-positive isolates were associated with ESBL, strong biofilm
production, and harbored fimH, mrkD, kpn, entB, hlyA, fyuA, and traT genes;
moreover, these isolates were sensitive only to meropenem. These characteristics
suggest that K. pneumoniae harboring cnf1 toxin genes have the potential to
become high-risk isolates in hospitals as they are capable to develop MDR
phenotype. Similar to our findings, a high frequency rate of biofilm formation
was reported in K. pneumoniae isolated from different countries [2, 18]. This may
be related to the significant prevalence of factors implicating in biofilm formation
such as type 1 or type 3 fimbriae and EntB [2, 19]. In this study, biofilm formation
was similar in K. pneumoniae isolated from inpatient and outpatient cases, which
suggests role of biofilm formation in bacterial colonization in both inpatients and
outpatients [20]. In this study, the isolates collected from inpatients were capable
to form a moderate and strong biofilm compared to outpatients that can be
associated with long hospitalization and challenges for treatment of inpatients.
This study in accordance with the results of Soto et al. [21] showed that isolates
containing hemolysin produced biofilm in moderate to strong that suggests that
colonization with hemolytic and biofilm producer isolates is more likely to
develop into UTIs. Furthermore, all isolates that had ability to forming HMV
were positive for hemolytic and biofilm production and it has been suggested that
VIRULENCE CHARACTERISTICS OF K. PNEUMONIAE 361
Acta Microbiologica et Immunologica Hungarica 66, 2019
this ability increases colonization of K. pneumoniae. Other recent studies also
identified that the HMV-producing isolates had higher biofilm than non-HMV
isolates [22, 23].
β-lactams, cephalosporins, and SXT are among the recommended antibiotics
for treatment of UTIs [24]. However, according to this study and others, it is
recommended that the use of these antibiotics, especially β-lactams, should be
limited [25, 26]. The frequent and misuse of these antibiotics has led to the high
resistance levels. On the contrary, our results and others showed the high effective-
ness of carbapenems, quinolones, and aminoglycosides against K. pneumoniae to be
considered as effective treatment agents, especially in complicated UTIs [24, 25].
Despite this, there are some studies that reported significant rate of resistance to
these antibiotics in K. pneumoniae [27, 28]. The variable results could be related to
the differences in geographical area, UTI type, sampling, and social habits of the
communities [29].
To date, infections caused by MDR K. pneumoniae have become a major
challenge for treatment, resulting in increased mortality rates and excessive costs
for patients [30]. MDR was observed in about 24% of the isolates that was lower
than studies in Nepal [31], Ethiopia [29], and China [32]. It is possible the
excessive use of antibiotics and lack of appropriate strategies for control of UTIs
increase the rate of MDR isolates in the societies [29].
In this study, 34.5% of isolates produced ESBL that was lower than the rate of
ESBL in other geographical regions of Iran (70% and 97%) [33, 34]. The studies
showed that the prevalence of ESBL in K. pneumoniaewas higher than 10% for half
of the countries in different geographical regions. These frequency rates were
variable from 0% in Iceland to 91% in Romania [35]. In this study, the frequency
rate of ESBLs among inpatient isolates was significantly higher than among
outpatient isolates. This could be due to the extensive use of different classes of
antibiotics in inpatients that increases the possibility of the ESBL acquisition as
compared to the outpatients [36]. Furthermore, high antibiotic resistance especially
MDR phenotype was found among ESBL-positive isolates as compared to non-
ESBL isolates, which can lead to serious difficulties in treatment of these patients.
In this study, 46 (95.8%) of phenotypically ESBL-positive isolates indicated
the presence of the ESBL genes. The absence of the ESBL genes in two of the
phenotypically ESBL-positive isolates suggests that ESBL production in these
isolates might be related to other classes of ESBLs, which requires further studies
[37]. In accordance with our findings, a high prevalence of CTX-M is reported
among the ESBL-positive strains from Asia, America, and Africa [35, 38, 39].
Furthermore, in agreement with the present study, an increased shift from TEM or
SHV to CTX-M genotype was shown in Europe [35, 38]; whereas in addition to
CTX-M, the high frequency of TEM and SHV genotypes was reported in Isfahan,
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Iran [39]. Different concurrent presence of ESBL genes is also reported from Iran
and other countries [35]. For example, on the contrary to our findings, the
simultaneous presence of blaSHV, blaCTX-M, and blaTEM genes was observed in
a study in Iran (37%) [33].
Some associations were found between the presence of virulence character-
istics and antibiotic resistance. In this regard, a correlation between the presence of
traT, fyuA, or cnf-1 genes with antibiotic resistance was observed. It was also found
that all resistant isolates to meropenem produced biofilm or isolates with HMV
property showed higher tendency to antibiotic resistance. Furthermore, all ESBL-
positive isolates were biofilm producers that moderate and strong biofilm production
was detected in 58.3% and 33.3% of ESBL producers, respectively. The prevalence
of HMV phenotype was higher among ESBL-producing isolates, where 12 (25%) of
ESBLs exhibited HMV compared to the non-ESBLs (5.4%) (p= 0.002). ESBL-
positive isolates tended to harbor some of the virulence genes such as fyuA and hlyA
more than ESBL-negative isolates (p< 0.05). It was also found that the isolates with
blaTEM genotype significantly harbored fyuA (p= 0.048) and hlyA virulence genes.
These correlations suggest that the co-presence of the virulence and resistance genes
on same mobile genetic elements may enhance their spread by horizontal gene
transfer [40].
In this study, 41 patterns in PFGE were observed that demonstrated the high
genetic variability of K. pneumoniae isolates in Tehran, Iran. This diversity
suggests that the isolates are obtained from different clones and may indicate
the good hygienic conditions in these hospitals. There were only two pulsotypes
that isolates in clone type C2 were collected from one hospital and with same
antibiotic resistance patterns (R8). This suggests that the isolates in C2 may
originate from one clone in this hospital and there is a risk of spreading the clone in
the hospital environments.
In conclusion, a significant rate of virulence factors and antibiotic resistance
was observed in K. pneumoniae isolates. Furthermore, the correlations were
observed between the antibiotic resistance and virulence characteristics in these
isolates that could increase their ability in pathogenicity in the urinary tract. These
findings and others indicate that improvement in strategies of antibiotic therapy
and control of UTIs caused by K. pneumoniae should be performed before the
emerging of MDR strains for which there are no effective antibiotics.
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